# Irreversible Electroporation (NanoKnife ®) and Immunotherapy for the Treatment of Stage IV Colorectal Cancer

> **NCT06047015** · PHASE1,PHASE2 · NOT_YET_RECRUITING · sponsor: **University of Saskatchewan** · enrollment: 12 (estimated)

## Conditions studied

- Liver Metastasis Colon Cancer

## Interventions

- **COMBINATION_PRODUCT:** IRE plus checkpoint inhibitor
- **COMBINATION_PRODUCT:** IRE plus Checkpoint Inhibitor plus CpG-ODN

## Key facts

- **NCT ID:** NCT06047015
- **Lead sponsor:** University of Saskatchewan
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-07
- **Primary completion:** 2027-12
- **Final completion:** 2028-12
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2024-08-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06047015

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06047015, "Irreversible Electroporation (NanoKnife ®) and Immunotherapy for the Treatment of Stage IV Colorectal Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06047015. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*